BioSig Technologies Faces Listing Rule Concerns
Ticker: STEX · Form: 8-K · Filed: Mar 18, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2024 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $1.00, $5,000,000 m, $35 m |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, compliance
TL;DR
BioSig Technologies might be in trouble with the stock exchange listing rules.
AI Summary
BioSig Technologies, Inc. filed an 8-K on March 18, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on March 12, 2024. The company is incorporated in Delaware and its principal executive offices are located at 55 Greens Farms Road, Westport, Connecticut.
Why It Matters
This filing indicates potential issues with BioSig Technologies' compliance with stock exchange listing requirements, which could impact its ability to remain publicly traded.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued public trading status.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- March 18, 2024 (date) — Filing Date
- March 12, 2024 (date) — Earliest Event Reported Date
- Delaware (jurisdiction) — State of Incorporation
- 55 Greens Farms Road, Westport, Connecticut 06880 (address) — Principal Executive Offices
FAQ
What specific listing rule or standard has BioSig Technologies failed to satisfy?
The filing does not specify the exact rule or standard that BioSig Technologies has failed to satisfy, only that a notice has been issued.
What is the potential consequence of failing to satisfy a continued listing rule?
The potential consequence is delisting from the stock exchange where the company's securities are traded.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 12, 2024.
What is the company's state of incorporation?
BioSig Technologies, Inc. is incorporated in Delaware.
Where are BioSig Technologies' principal executive offices located?
The principal executive offices are located at 55 Greens Farms Road, Westport, Connecticut.
Filing Stats: 835 words · 3 min read · ~3 pages · Grade level 15.8 · Accepted 2024-03-18 06:03:26
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
- $1.00 — k did not meet the minimum bid price of $1.00 per share required for continued listin
- $5,000,000 m — se the Company does not comply with the $5,000,000 minimum stockholders' equity initial list
- $35 m — um Market Value of Listed Securities of $35 million, if none of the other standards s
Filing Documents
- form8-k.htm (8-K) — 42KB
- 0001493152-24-010175.txt ( ) — 211KB
- bsgm-20240312.xsd (EX-101.SCH) — 3KB
- bsgm-20240312_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240312_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: March 15, 2024 By: /s/ Frederick D. Hrkac Name: Frederick D. Hrkac Title: Principal Executive Officer